• Brazil: New criteria for priority drug review

    A public consultation on new criteria for prioritizing the review of drug approval applications is planned by Brazil's regulatory agency, ANVISA.  The agency intends to propose a point system for determining which drugs should be "placed in front of the queue for review."  According to the agency, an example of a marketing approval application that would get priority is for a generic version of a brand name drug that has no market competition.  Read...